| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6609 |
| Human Intestinal Absorption | HIA- | 0.8407 |
| Caco-2 Permeability | Caco2- | 0.8957 |
| P-glycoprotein Substrate | Non-substrate | 0.5805 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8575 |
| Non-inhibitor | 0.9425 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8490 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7211 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8745 |
| CYP450 2D6 Substrate | Non-substrate | 0.8540 |
| CYP450 3A4 Substrate | Non-substrate | 0.6605 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9472 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9556 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9386 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9134 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9774 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9619 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9692 |
| Non-inhibitor | 0.8684 |
| AMES Toxicity | Non AMES toxic | 0.9421 |
| Carcinogens | Non-carcinogens | 0.9569 |
| Fish Toxicity | Low FHMT | 0.7646 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5575 |
| Honey Bee Toxicity | High HBT | 0.7253 |
| Biodegradation | Not ready biodegradable | 0.6719 |
| Acute Oral Toxicity | IV | 0.5349 |
| Carcinogenicity (Three-class) | Non-required | 0.6723 |